Evaluation of α-Synuclein and Apolipoprotein E as Potential Biomarkers in Cerebrospinal Fluid to Monitor Pharmacotherapeutic Efficacy in Dopamine Dictated Disease States of Parkinson’s Disease and Schizophrenia [Corrigendum]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249345/
https://www.ncbi.nlm.nih.gov/pubmed/35784514
http://dx.doi.org/10.2147/NDT.S379262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249345/
https://www.ncbi.nlm.nih.gov/pubmed/35784514
http://dx.doi.org/10.2147/NDT.S379262

Ejemplares similares